Skip to main content
. 2022 Sep 27;12:942122. doi: 10.3389/fonc.2022.942122

Table 1.

2004–2018 Basic Situation of Non-Hodgkin lymphoma Incidence.

2004-2008 (N=52228) 2009-2013 (N=56010) 2014-2018 (N=63194)
Sex
 Male 27682 (53.0%) 30312 (54.1%) 34587 (54.7%)
 Female 24546 (47.0%) 25698 (45.9%) 28607 (45.3%)
Race
 American Indian/Alaska Native 238 (0.4%) 322 (0.6%) 326 (0.5%)
 Asian or Pacific Islander 3402 (6.5%) 4223 (7.5%) 5385 (8.5%)
 Black 3961 (7.6%) 4474 (8.0%) 4949 (7.8%)
 White 37909 (72.6%) 38470(68.7%) 41657 (65.9%)
Diagnosis age
 15-44 7697 (14.7%) 7461 (13.3%) 7531(11.9%)
 45-54 8160 (15.6%) 8425 (15.0%) 8299 (13.1%)
 55-64 10497 (20.1%) 12442 (22.2%) 14535 (23.0%)
 65-74 10636 (20.4%) 12527 (22.4%) 16336 (25.9%)
 75+ 15238 (29.2%) 15155 (27.1%) 16493 (26.1%)
Primary Site
 Extranodal 16529 (31.6%) 19283 (34.4%) 22511 (35.6%)
 Nodal 35699(68.4%) 36727(65.6%) 40683 (64.4%)
Area
 Rural 45612(87.3%) 49625(88.6%) 56451(89.3%)
 Urban 6563(12.6%) 6316(11.3%) 6697(10.6%)
Histology
 CLL/SLL 2923 (5.6%) 2435 (4.3%) 2843 (4.5%)
 DLBCL 19379 (37.1%) 20953 (37.4%) 23708 (37.5%)
 FL 9959 (19.1%) 9788(21.7%) 10919 (17.3%)
 MCL 1937 (3.7%) 2359(4.2%) 2833 (4.5%)
 MZL 4575 (8.8%) 5476 (9.8%) 6586(10.4%)
 PTCL 3237 (6.2%) 3448 (6.2%) 3716 (5.9%)